Evaluation of the Semmes–Weinstein filaments and a questionnaire to assess chemotherapy-induced peripheral neuropathy

Simão, Delma Aurélia da Silva; Teixeira, Antônio Lúcio; Souza, Raissa Silva; Lima, Elenice Dias Ribeiro de Paula

doi:10.1007/s00520-014-2275-3

Cited by 22 publications

(18 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…SWM was developed to assess tactile point pressure sensitivity threshold (on hands and feet), hence identifying peripheral neuropathy in the clinical setting even in subclinical cases, but is not valuable to quantify CIPN [16]. Nevertheless it can underestimate small fiber CIPN.…”

Section: Neurophysiologic Tests and Other Medical Devicesmentioning

confidence: 99%

Chemotherapy-induced peripheral neuropathy in the adult

Saad

Tafani

Psimaras

et al. 2014

Current Opinion in Oncology

View full text Add to dashboard Cite

CIPN is a common, potentially severe and dose-limiting adverse effect of cancer treatment. Chemotherapies mainly target axons, dorsal root ganglia and terminal trees of intraepidermal nerve fibers. A quick and noninvasive method allowing the assessment of CIPN should be developed, although no treatment prevents CIPN or improves its long-term course. Furthermore, symptomatic therapy is often largely ineffective in reducing CIPN symptoms.

show abstract

Section: Neurophysiologic Tests and Other Medical Devicesmentioning

confidence: 99%

Chemotherapy-induced peripheral neuropathy in the adult

Saad

Tafani

Psimaras

et al. 2014

Current Opinion in Oncology

View full text Add to dashboard Cite

show abstract

“…Impaired tactile sensory perception is a subjective problem, that is, patients need to communicate their symptoms, which should be highlighted as a recommendation when care is provided to cancer patients receiving neurotoxic ACH 11 . A total of 57% of the population under study presented altered tactile sensory perception and reported physical weariness due to the treatment including paresthesia in both hands and feet, discomfort in the upper limbs, lack of or decreased touch sensitivity and hypoesthesia, situations widely reported in the literature 5 - 9 , 11 . The rates of impaired tactile sensory perception reported in the literature range from 51% and 98% 6 - 7 , 10 - 11 , depending on the type of medication involved.…”

Section: Discussionmentioning

confidence: 99%

“…Note that the translated version of the AINQ validated for Brazilian Portuguese 11 includes the occurrence of neurological changes in both the upper and lower limbs, as well as the person’s ability to perform DLA during ACH.…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Risk prediction and impaired tactile sensory perception among cancer patients during chemotherapy

Cardoso

Araújo

Chianca

2018

Rev. Latino-Am. Enfermagem

View full text Add to dashboard Cite

Objectives:to estimate the prevalence of impaired tactile sensory perception, identify risk factors, and establish a risk prediction model among adult patients receiving antineoplastic chemotherapy. Method:historical cohort study based on information obtained from the medical files of 127 patients cared for in the cancer unit of a private hospital in a city in Minas Gerais, Brazil. Data were analyzed using descriptive and bivariate statistics, with survival and multivariate analysis by Cox regression. Results:57% of the 127 patients included in the study developed impaired tactile sensory perception. The independent variables that caused significant impact, together with time elapsed from the beginning of treatment up to the onset of the condition, were: bone, hepatic and regional lymph node metastases; alcoholism; palliative chemotherapy; and discomfort in lower limbs. Conclusion:impaired tactile sensory perception was common among adult patients during chemotherapy, indicating the need to implement interventions designed for early identification and treatment of this condition.

show abstract

“…Para Revista Brasileira de Cancerologia 2019; 65(2): e-04392 1-9 avaliação de sintomas de ansiedade e depressão, utilizou-se a escala hospitalar de ansiedade e depressão (do inglês, Hospital Anxiety and Depression Scale -HAD) 10,11 . A dor foi avaliada utilizando o questionário de dor McGill, em sua forma reduzida -Short Form McGill Questionnaire (SF-MPQ) 12,13 . Para a avaliação da NPIQ, adotaram-se as seguintes estratégias: autorrelato de sintomas; exame clínico neurológico e avaliação utilizando o questionário de neurotoxicidade induzida por antineoplásicos (CINQ); um questionário validado para a população brasileira a partir de um estudo desenvolvido por Simão et al 13 , que obteve, na análise de concordância, índice Kappa=0,320 (p<0,001) e correlação moderada e positiva (p= 0,357; p<0,001) ao comparar o CINQ ao método do estesiômetro ou monofilamentos de Semmes-Weinstein (MSW).…”

Section: Métodounclassified

Evolução Clínica e Preditores da Neuropatia Periférica Induzida por Quimioterapia

Simão

Abreu

Gómez

et al. 2019

Rev. Brasileira.De.Cancerologia

Self Cite

View full text Add to dashboard Cite

Introdução: Drogas antineoplásicas neurotóxicas estão frequentemente associadas à neuropatia periférica induzida por quimioterapia (NPIQ). Objetivo: Avaliar a evolução clínica dos pacientes expostos a tratamento antineoplásico potencialmente neurotóxico e identificar possíveis preditores clínicos e sociodemográficos para o desenvolvimento da NPIQ. Método: Estudo de coorte prospectiva com pacientes com diagnóstico de câncer de mama, ovário ou intestino em tratamento quimioterápico com paclitaxel, docetaxel ou oxaliplatina. Foram avaliados antes da quimioterapia (T1), no terceiro mês (T2) e 30-60 dias após interrupção do tratamento (T3). Todos responderam ao questionário de perfis sociodemográfico e clínico, foram avaliados por meio de exame clínico neurológico, pela escala de performance ECOG, escala hospitalar de ansiedade e depressão (HAD), escala de dor Short-cGuill, autorrelato de sintomas de NPIQ e avaliação com o questionário de neurotoxicidade induzida por antineoplásicos (CINQ). Resultados: Por meio de autorrelato, 75% da dos pacientes informaram apresentar sintomas de NPIQ. O CINQ evidenciou que 90% apresentaram algum grau de NPIQ em T2, enquanto 82,5% ainda persistiam em T3. Dor neuropática acometeu 42% da população (RR=1,429; IC95%=1,130-1,806). Os escores de ansiedade e depressão reduziram significativamente quando comparados ao início de tratamento (redução de 2,5 pontos na escala HAD, p<0,05). A capacidade funcional da população não mostrou alterações significativas. No T2, a escolaridade foi considerada preditora para autorrelato de sintomas de NPIQ (OR=1,314, IC95%=1,002-1,723, p=0,048). Conclusão: A baixa escolaridade pode comprometer a capacidade do paciente em relatar os sintomas da NPIQ. Este estudo chama a atenção para a necessidade de utilização de instrumentos específicos para detecção precoce da NPIQ.

show abstract

Evaluation of the Semmes–Weinstein filaments and a questionnaire to assess chemotherapy-induced peripheral neuropathy

Abstract: CINQ and SWM may be valid tools for diagnosing CIPN in oncology practice. SWM may identify subclinical CIPN.

Cited by 22 publications

References 26 publications

Chemotherapy-induced peripheral neuropathy in the adult

Chemotherapy-induced peripheral neuropathy in the adult

Risk prediction and impaired tactile sensory perception among cancer patients during chemotherapy

Evolução Clínica e Preditores da Neuropatia Periférica Induzida por Quimioterapia

Contact Info

Product

Resources

About